Pharmacotherapy to protect ovarian function and fertility during cancer treatment

Matteo Lambertini; Chiara Dellepiane; Giulia Viglietti; Lucia Del Mastro

doi:10.1080/14656566.2017.1316373

Pharmacotherapy to protect ovarian function and fertility during cancer treatment

Expert Opin Pharmacother. 2017 Jun;18(8):739-742. doi: 10.1080/14656566.2017.1316373. Epub 2017 Apr 11.

Authors

Matteo Lambertini^{1

2}, Chiara Dellepiane³, Giulia Viglietti¹, Lucia Del Mastro³

Affiliations

¹ a Breast Cancer Translational Research Laboratory , Institut Jules Bordet and l'Université Libre de Bruxelles (U.L.B.) , Brussels , Belgium.
² b BrEAST Data Centre, Department of Medicine , Institut Jules Bordet and l'Université Libre de Bruxelles (U.L.B.) , Brussels , Belgium.
³ c Department of Medical Oncology , U.O. Sviluppo Terapie Innovative, IRCCS AOU San Martino-IST , Genova , Italy.

PMID: 28399670
DOI: 10.1080/14656566.2017.1316373

No abstract available

Keywords: GnRHa; Gonadotropin-releasing hormone analogs; breast cancer; fertility preservation; lymphoma; ovarian function preservation; young patients.